{
    "code": "01036967",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01036967",
    "time": "2021-05-21 04:51:04",
    "許可證字號": "衛署藥製字第036967號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/11\/24",
    "發證日期": "82\/11\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103696701",
    "中文品名": "〝台裕〞菲碧茵肌肉注射液５０毫克／毫升（可多普洛菲）",
    "英文品名": "Febin I.M. Injection 50mg\/ml &quot;Tai Yu&quot;(Ketoprofen)",
    "適應症": "鎮痛、解熱、消炎（慢性關節炎、變形性關節炎及外傷手術後之疼痛）。",
    "劑型": "270注射劑",
    "包裝": "盒裝 安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "KETOPROFEN",
    "限制項目": "01國　產",
    "申請商名稱": "1402206200  台裕化學製藥廠股份有限公司",
    "申請商地址": "新竹縣竹東鎮員山路１１巷１３弄１號",
    "主製造廠": [
        {
            "製造廠名稱": "1402206300  臺裕化學製藥廠股份有限公司",
            "製造廠廠址": "新竹縣竹東鎮員山路11巷13弄1號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808401600",
            "成分名稱": "KETOPROFEN",
            "含量描述": "50",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "2ml",
        "特殊劑型": "",
        "顏色": "無色或微黃色",
        "特殊氣味": "無",
        "刻痕": "無",
        "形狀": "長圓柱形",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "[外觀]036967菲碧茵肌肉注射液(可多普洛菲)(2毫升／50毫克)-104-12-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01036967&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "036967菲碧茵50毫克-F-20170809-106-08-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01036967&Seq=005&Type=9"
        },
        {
            "title": "036967菲碧茵50毫克-E-20170105.-106-06-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01036967&Seq=004&Type=9"
        },
        {
            "title": "036967菲碧茵50毫克-D-104-12-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01036967&Seq=003&Type=9"
        },
        {
            "title": "[外盒]036967菲碧茵肌肉注射液(可多普洛菲)(2毫升／50毫克)-104-12-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01036967&Seq=002&Type=8"
        }
    ]
}